1 We wanted to address how single engagement versus cotargeting
2 As an alternative to the use of viral vectors,
we wanted to assess the efficacy of synthetic miRNA mimics in
3 ion contributes to poor outcome in critically ill patients,
we wanted to assess the prognostic value of secretoneurin in
4 We wanted to assess the role of mucosal mononuclear phagocyte
5 We wanted to assess whether a network of hospitals, linked by
6 Thus,
we wanted to check whether the health care setting has an imp
7 We wanted to compare clopidogrel with ticagrelor, a potent an
8 ection for DENV vaccines on the basis of cellular immunity,
we wanted to compare the cellular immune response to this cha
9 We wanted to confirm these observations on a cohort of patien
10 or virus discovery, particularly in pathological specimens,
we wanted to determine how universal immunostaining for dsRNA
11 hich controls messenger RNA generation-are poorly described.
We wanted to determine the effects of 6 mo of dietary supplem
12 On the basis of these data,
we wanted to determine the lifetime health benefits and healt
13 We wanted to determine the long-term renal effects of empagli
14 First,
we wanted to determine whether a frontocentral ERP was elicit
15 In the present study,
we wanted to determine whether it is possible to immediately
16 We wanted to determine whether prescription of dabigatran or
17 We wanted to determine whether SIRT5 is activated by protein
18 We wanted to determine whether tau reduction may also be of b
19 We wanted to elucidate the status of Noxa in H. pylori-infect
20 We wanted to estimate the FEV1/FVC ratio z score threshold wi
21 We wanted to evaluate the feasibility and efficacy of PN moni
22 We wanted to examine the effect of adding a third oral agent,
23 We wanted to examine tolerability and efficacy of NSI-189, a
24 (IPSA) can improve the quality of brachytherapy plans, and
we wanted to examine whether IPSA could improve cervical canc
25 More specifically,
we wanted to examine whether the capacity to infect host larv
26 We wanted to explore its potential for improving diagnosis an
27 l pharmacological targets to fight against obesity and T2D,
we wanted to explore the metabolic impact of this compound in
28 In this study
we wanted to explore the regulatory properties of CD24(high)C
29 We wanted to explore whether an undiscovered RNA-based signal
30 In the present paper,
we wanted to extend this work to older adults and investigate
31 We wanted to find out whether a male human leukocyte antigen
32 We wanted to help fill this knowledge gap and investigated ef
33 We wanted to identify factors correlated with poor long-term
34 We wanted to identify TSLP-responding DC populations in the h
35 Here
we wanted to investigate the differential expression of the T
36 We wanted to investigate the relative significance of fat and
37 In the present study,
we wanted to investigate the role of regulatory T (Treg) cell
38 In this pilot study,
we wanted to investigate whether hen's egg allergen is detect
39 We wanted to know how breeder turnover affects group composit
40 We wanted to know if the non-pathogenic serotype Kentucky imp
41 We wanted to measure geographical variation in skin prick tes
42 Here,
we wanted to probe whether such cross-modal attention effects
43 We wanted to prospectively investigate intratumor heterogenei
44 With this study,
we wanted to prove the hypothesis that the unique extracellul
45 To this end,
we wanted to report the utility of an unexplored unnatural am
46 We wanted to see if having access to primary care or insuranc
47 We wanted to study the role of endogenous Mfn2 in cell prolif
48 We wanted to test the association epidemiologically by assess
49 In this study,
we wanted to understand the effects of chemically processed r
50 We wanted to understand the role of the actin nucleator Arp2/